BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• BioForest

  BIOTRONIK SE & Co.KG Announces Conclusion Of Full-Body ProMRI Pacemaker Study

  December 9, 2014

   · 

  1 min read
• NIHR Announces Pioneering Study To Test New Treatment For Sjogren’s Syndrome

  December 9, 2014

   · 

  3 min read
• Business

  N-of-One Expands Executive Team To Meet Market Demand

  December 9, 2014

   · 

  2 min read
• BioMidwest

  Endurant “AAA” Stent Graft From Medtronic, Inc. Continues To Deliver Durable, Consistent And Proven Outcomes

  December 9, 2014

   · 

  4 min read
• Drug Development

  Juno Therapeutics’s CAR T and TCR Investigational Product Candidates Demonstrate Promising Outcomes In Clinical Trials In Patients With B-Cell Cancers

  December 9, 2014

   · 

  7 min read
• Drug Development

  Epizyme First-In-Class PRMT5 Inhibitor Demonstrates In Vitro And In Vivo Activity In Models Of Mantle Cell Lymphoma

  December 9, 2014

   · 

  4 min read
• Drug Development

  Celgene Release: REVLIMID® (Lenalidomide) Single-Agent And Combination Studies In Mantle Cell Lymphoma (MCL) Presented At American Society of Hematology

  December 9, 2014

   · 

  20 min read
• Drug Development

  Epizyme DOT1L Inhibitor EPZ-5676 Shows Clinical And Biological Activity In Adult Patients With Acute Leukemias In Phase 1 Trial

  December 9, 2014

   · 

  7 min read
• Pharm Country

  Arno Therapeutics To Present Data Further Validating Diagnostic Development Of CDX For Onapristone At San Antonio Breast Cancer Symposium 2014

  December 9, 2014

   · 

  6 min read
• Drug Development

  Ariad Pharmaceuticals, Inc. Announces Long-Term Safety And Efficacy Data Of Ponatinib In Chronic-Phase Chronic Myeloid Leukemia From Phase 1 Clinical Trial

  December 9, 2014

   · 

  14 min read